Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Best of the Week: Key info for healthcare workers receiving a COVID-19 vaccine | 2 new recalls | Sacubitril/valsartan for HFpEF
Saturday, February 6, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

CDC shares a new warning for healthcare workers receiving a COVID-19 vaccine

Healthcare workers should pay close attention to any symptoms they experience after receiving a COVID-19 vaccine, according to a new analysis.

READ MORE >
Covid Vaccine
Share on Twitter Share on Facebook Share on Linkedin

CDC shares a new warning for healthcare workers receiving a COVID-19 vaccine

Share on Twitter Share on Facebook Share on Linkedin
Covid Vaccine
Healthcare workers should pay close attention to any symptoms they experience after receiving a COVID-19 vaccine, according to a new analysis.
READ MORE >

Casana raises $14M to bring toilet seat-based heart monitoring system to market

Casana, formerly known as Heart Health Intelligence, also named a new CEO. 

READ MORE >
heart monitor toilet seat
Share on Twitter Share on Facebook Share on Linkedin

Casana raises $14M to bring toilet seat-based heart monitoring system to market

Share on Twitter Share on Facebook Share on Linkedin
heart monitor toilet seat
Casana, formerly known as Heart Health Intelligence, also named a new CEO. 
READ MORE >

FDA announces yet another new recall for extended-release metformin due to contamination

This is the second voluntary recall for extended-release metformin of 2021. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA announces yet another new recall for extended-release metformin due to contamination

Share on Twitter Share on Facebook Share on Linkedin
This is the second voluntary recall for extended-release metformin of 2021. 
READ MORE >

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  
READ MORE >

Sacubitril/valsartan improves self-reported quality of life for HFpEF patients

However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Sacubitril/valsartan improves self-reported quality of life for HFpEF patients

Share on Twitter Share on Facebook Share on Linkedin
However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.
READ MORE >

Explained: 4 key takeaways from the 2020 ACC/AHA valvular heart disease guidelines

Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.

READ MORE >
doctors.jpg
Share on Twitter Share on Facebook Share on Linkedin

Explained: 4 key takeaways from the 2020 ACC/AHA valvular heart disease guidelines

Share on Twitter Share on Facebook Share on Linkedin
doctors.jpg
Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.
READ MORE >

7 risk factors associated with death and cardiovascular events among hospitalized COVID-19 patients

Even with numerous vaccines now being distributed, the COVID-19 pandemic continues to cause havoc for health systems all over the world. 

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

7 risk factors associated with death and cardiovascular events among hospitalized COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
Even with numerous vaccines now being distributed, the COVID-19 pandemic continues to cause havoc for health systems all over the world. 
READ MORE >

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant. 

READ MORE >
tea coffee drink quiet read
Share on Twitter Share on Facebook Share on Linkedin

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Share on Twitter Share on Facebook Share on Linkedin
tea coffee drink quiet read
Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant. 
READ MORE >

Researchers examine ‘concerning’ out-of-hospital 30-day mortality rate for TAVR patients

Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018. 

READ MORE >
home rehab
Share on Twitter Share on Facebook Share on Linkedin

Researchers examine ‘concerning’ out-of-hospital 30-day mortality rate for TAVR patients

Share on Twitter Share on Facebook Share on Linkedin
home rehab
Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018. 
READ MORE >

AI model IDs high-risk cardiovascular patients based on imaging data

The algorithm can help physicians make key decisions about a patient’s health, including whether or not it is time to consider statin therapy. 

READ MORE >
Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients. A new analysis in European Heart Journal explored that exact issue, providing cardiology professionals with a step-by-step breakdown of how to get the most out of this potentially game-changing technology.
Share on Twitter Share on Facebook Share on Linkedin

AI model IDs high-risk cardiovascular patients based on imaging data

Share on Twitter Share on Facebook Share on Linkedin
Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients. A new analysis in European Heart Journal explored that exact issue, providing cardiology professionals with a step-by-step breakdown of how to get the most out of this potentially game-changing technology.
The algorithm can help physicians make key decisions about a patient’s health, including whether or not it is time to consider statin therapy. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme